Maithri Labs

Maithri Laboratories is a prominent Indian pharmaceutical company focused on the development and large-scale manufacturing of Active Pharmaceutical Ingredients (APIs) and advanced intermediates. As a key subsidiary of the MSN Group, the company leverages robust R&D capabilities to produce high-quality chemical entities for diverse therapeutic segments, including oncology, cardiology, and infectious diseases. Maithri operates multiple manufacturing units that adhere to stringent global regulatory standards such as the US FDA and EU GMP. The company gained international visibility for its rapid production of essential antiviral treatments during the COVID-19 pandemic. Their integrated business model supports both generic drug manufacturers and innovator companies through contract development and manufacturing services.